Heba Alnakhala

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Harvard University(Current)

Purdue University West Lafayette

Brigham and Women's Hospital

Heba Alnakhala is an author at Harvard University specializing in molecular pharmacology, neurodegenerative disorders, and protein aggregation inhibition.

Publications per year

2023–2024

Publications

Discovery of small molecule benzothiazole and indole derivatives tackling tau 2N4R and α-synuclein fibrils

Ahmed A. Elbatrawy, Taiwo A. Ademoye, Heba Alnakhala et al. · Bioorganic & Medicinal Chemistry · 2024 · 18 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +16

5-Nitro-1,2-benzothiazol-3-amine and <i>N</i>-Ethyl-1-[(ethylcarbamoyl)(5-nitro-1,2-benzothiazol-3-yl)amino]formamide Modulate α-Synuclein and Tau Aggregation

Eduardo Ramirez, Susantha K. Ganegamage, Ahmed A. Elbatrawy et al. · ACS Omega · 2023 · 10 citations · Full text

Life Sciences, Medicinal Chemistry, Neuroscience +17

1–2 of 2